BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19139100)

  • 1. Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis.
    Pamuklar Z; Federico L; Liu S; Umezu-Goto M; Dong A; Panchatcharam M; Fulkerson Z; Berdyshev E; Natarajan V; Fang X; van Meeteren LA; Moolenaar WH; Mills GB; Morris AJ; Smyth SS
    J Biol Chem; 2009 Mar; 284(11):7385-94. PubMed ID: 19139100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of lysophospholipase D/autotaxin activity in human serum samples.
    Nakamura K; Ohkawa R; Okubo S; Tozuka M; Okada M; Aoki S; Aoki J; Arai H; Ikeda H; Yatomi Y
    Clin Biochem; 2007 Feb; 40(3-4):274-7. PubMed ID: 17222397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
    Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of inhibitory actions of flavonols and related substances on lysophospholipase d activity of serum autotaxin by a convenient assay using a chromogenic substrate.
    Ueda K; Yoshihara M; Nakao M; Tanaka T; Sano S; Fukuzawa K; Tokumura A
    J Agric Food Chem; 2010 May; 58(10):6053-63. PubMed ID: 20415488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
    J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity.
    Tokumura A; Kume T; Fukuzawa K; Tahara M; Tasaka K; Aoki J; Arai H; Yasuda K; Kanzaki H
    Life Sci; 2007 Apr; 80(18):1641-9. PubMed ID: 17367815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients.
    Nakamura K; Takeuchi T; Ohkawa R; Okubo S; Yokota H; Tozuka M; Aoki J; Arai H; Ikeda H; Ohshima N; Kitamura T; Yatomi Y
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):549-56. PubMed ID: 17961310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin.
    Block RC; Duff R; Lawrence P; Kakinami L; Brenna JT; Shearer GC; Meednu N; Mousa S; Friedman A; Harris WS; Larson M; Georas S
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(2-3):87-95. PubMed ID: 20106646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of autotaxin/lysophospholipase D activity.
    Morris AJ; Smyth SS
    Methods Enzymol; 2007; 434():89-104. PubMed ID: 17954243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.
    Ferguson CG; Bigman CS; Richardson RD; van Meeteren LA; Moolenaar WH; Prestwich GD
    Org Lett; 2006 May; 8(10):2023-6. PubMed ID: 16671772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of autotaxin/lysophospholipase D results in head cavity formation in mouse embryos through the LPA receptor-Rho-ROCK pathway.
    Koike S; Keino-Masu K; Masu M
    Biochem Biophys Res Commun; 2010 Sep; 400(1):66-71. PubMed ID: 20692235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
    David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
    PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
    van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J
    Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
    Federico L; Pamuklar Z; Smyth SS; Morris AJ
    Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediators of pruritus during cholestasis.
    Oude Elferink RP; Kremer AE; Beuers U
    Curr Opin Gastroenterol; 2011 May; 27(3):289-93. PubMed ID: 21451412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids.
    Nakamura K; Kishimoto T; Ohkawa R; Okubo S; Tozuka M; Yokota H; Ikeda H; Ohshima N; Mizuno K; Yatomi Y
    Anal Biochem; 2007 Aug; 367(1):20-7. PubMed ID: 17568554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
    Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
    Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin.
    Billon-Denis E; Tanfin Z; Robin P
    J Lipid Res; 2008 Feb; 49(2):295-307. PubMed ID: 18024704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Submucosal connective tissue-type mast cells contribute to the production of lysophosphatidic acid (LPA) in the gastrointestinal tract through the secretion of autotaxin (ATX)/lysophospholipase D (lysoPLD).
    Mori K; Kitayama J; Aoki J; Kishi Y; Shida D; Yamashita H; Arai H; Nagawa H
    Virchows Arch; 2007 Jul; 451(1):47-56. PubMed ID: 17554559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.